This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Molecular and functional analysis of monoclonal antibodies in support of biologics development
Protein & Cell Open Access 21 July 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Acknowledgements
The views expressed in this article are personal to the authors and do not necessarily reflect those of other members of Foley & Lardner LLP or its clients.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Foley & Lardner LLP represents clients in the biologic and biosimilars space, including one or more companies mentioned in the article. The article is based entirely on publicly available information and does not reflect any confidential information.
Related links
PowerPoint slides
Rights and permissions
About this article
Cite this article
Brinckerhoff, C., Schorr, K. Have the biosimilar floodgates been opened in the United States?. Nat Rev Drug Discov 14, 303–304 (2015). https://doi.org/10.1038/nrd4622
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4622